Metsera is taking a ‘Lego kit’ approach to finding a next-generation weight-loss treatment. Biopharma startup Metsera turned heads in April when it emerged from stealth, announcing $290 million in funding from prestigious backers—an all-star roster of scientists and executives—and a portfolio of drug assets all focused on what may be the most lucrative pharmaceutical opportunity ever: obesity.
This Obesity-drug Startup Emerged From Stealth With $290 Million And Plans To Take On Wegovy And Zepbound
Adam Bluestein, Fast Company
Mon, 06/10/2024 - 8:00am
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more